FindTrial
Sign In

The effect of different markers in blood at the time of ICU admission on the patient outcome.

To study the prognostic value of Serum Procalcitonin, S NTProBNP as compared to APACHE IV on ICU admission in a mixed intensive care unit of Medanta The Medicity

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2012/12/003215
Enrollment
100
Registered
2012-12-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- All patients with Procalcitonin, NTProBNP measurements on ICU admission

Interventions

None listed

Sponsors

MedantaThe Medicity
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -Above 18 years of age will be eligible for participation into the study -ICU stay of more than 24 hrs

Exclusion criteria

Exclusion criteria: All patients without PCT, NTProBNP measurements on ICU admission would be excluded

Design outcomes

Primary

MeasureTime frame
All cause ICU mortalityTimepoint: 34months—

Secondary

MeasureTime frame
Length of ICU stay . need for ventilatory support. need for inotropic support Timepoint: 34months—

Countries

India

Contacts

Public ContactDrChitra Mehta

Medanta-The Medicity

mehtachitra@hotmail.com0124-4141414

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026